Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company is headquartered in Tarrytown, New York.
| Revenue (TTM) | $1.10B |
| Gross Profit (TTM) | $628.90M |
| EBITDA | $364.98M |
| Operating Margin | 29.10% |
| Return on Equity | 10.30% |
| Return on Assets | 6.13% |
| Revenue/Share (TTM) | $22.52 |
| Book Value | $38.66 |
| Price-to-Book | 1.43 |
| Price-to-Sales (TTM) | 2.42 |
| EV/Revenue | 3.285 |
| EV/EBITDA | 10.71 |
| Quarterly Earnings Growth (YoY) | -20.50% |
| Quarterly Revenue Growth (YoY) | -2.40% |
| Shares Outstanding | $47.32M |
| Float | $46.75M |
| % Insiders | 1.30% |
| % Institutions | 111.38% |